XML 175 R64.htm IDEA: XBRL DOCUMENT v3.21.4
Shareholders' Equity - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Jul. 09, 2019
Oct. 31, 2021
Dec. 31, 2019
Oct. 29, 2019
Weighted average grant-date fair value        
Unvested shares outstanding, modified (in shares)   26,000    
CEO Award        
Number of options outstanding        
Options outstanding, beginning of period (in shares)   1,700,000    
Stock option grant (in shares) 1,700,000 0    
Exercise of stock options (in shares)   0    
Stock options forfeited (in shares)   0    
Options outstanding, end of period (in shares)   1,700,000    
Weighted-average exercise price        
Weighted-average exercise price outstanding (in usd per share) (beginning of period)   $ 13.74    
Weighted-average exercise price of options exercised (in usd per share)   13.74    
Weighted-average exercise price outstanding (in usd per share) (end of period)   $ 13.74    
Weighted-average remaining life        
Weighted-average remaining life of options outstanding (in years)   7 years 8 months 12 days    
Aggregate intrinsic value        
Aggregate intrinsic value of options outstanding   $ 8.9 $ 5.6 $ 11.3
Number of options unvested        
Options unvested, beginning of period (in shares)   680,000    
Options vested (in shares)   (170,000)    
Options unvested, end of period (in shares)   510,000    
Weighted average grant-date fair value        
Weighted average grant-date fair value of options unvested (in usd per share) (beginning of period)   $ 5.35    
Weighted-average grant-date fair value of options (in usd per share)   5.35    
Weighted average grant-date fair value of options unvested (in usd per share) (end of period)   $ 5.35    
Options vested and expected to vest (in shares)   1,700,000    
Options exercisable (in shares)   1,190,000    
Weighted-average exercise price of options vested and expected to vest (in usd per share)   $ 13.74    
Weighted-average exercise price of options exercisable (in usd per share)   $ 13.74    
Weighted-average remaining life of options vested and expected to vest (in years)   7 years 8 months 12 days    
Weighted-average remaining life of options exercisable (in years)   7 years 8 months 12 days    
Aggregate intrinsic value of options vested and expected to vest   $ 8.9    
Aggregate intrinsic value of options exercisable   $ 6.2    
CEO Award | Maximum        
Number of options outstanding        
Exercise of stock options (in shares)   (500,000)    
2020 Incentive Award Plan        
Number of options outstanding        
Options outstanding, beginning of period (in shares)   698,000    
Stock option grant (in shares)   0    
Exercise of stock options (in shares)   (22,000)    
Stock options forfeited (in shares)   (190,000)    
Options outstanding, end of period (in shares)   486,000    
Weighted-average exercise price        
Weighted-average exercise price outstanding (in usd per share) (beginning of period)   $ 11.62    
Weighted-average exercise price of options exercised (in usd per share)   10.19    
Weighted-average exercise price of options forfeited (in usd per share)   12.00    
Weighted-average exercise price outstanding (in usd per share) (end of period)   $ 11.55    
Weighted-average remaining life        
Weighted-average remaining life of options outstanding (in years)   8 years 2 months 12 days    
Aggregate intrinsic value        
Aggregate intrinsic value of options outstanding   $ 3.6    
Number of options unvested        
Options unvested, beginning of period (in shares)   664,000    
Options vested (in shares)   (112,000)    
Options unvested, end of period (in shares)   362,000    
Weighted average grant-date fair value        
Weighted average grant-date fair value of options unvested (in usd per share) (beginning of period)   $ 3.61    
Weighted-average grant-date fair value of options (in usd per share)   3.61    
Weighted average grant-date fair value of options unvested (in usd per share)   3.61    
Weighted average grant-date fair value of options unvested (in usd per share) (end of period)   $ 3.99    
Options vested and expected to vest (in shares)   486,000    
Options exercisable (in shares)   124,000    
Weighted-average exercise price of options vested and expected to vest (in usd per share)   $ 11.55    
Weighted-average exercise price of options exercisable (in usd per share)   $ 10.23    
Weighted-average remaining life of options vested and expected to vest (in years)   8 years 2 months 12 days    
Weighted-average remaining life of options exercisable (in years)   7 years 7 months 6 days    
Aggregate intrinsic value of options vested and expected to vest   $ 3.6    
Aggregate intrinsic value of options exercisable   $ 1.1